Clinical Publications

EDITORIALS |
||
Bell RC. The time for TIF is now – the EsophyX Device is ready and able. Surgical Endoscopy (submitted in May 2009). |
||
Trad KS. Will Transoral Incisionless Fundoplication (TIF) cause a paradigm shift in the treatment of gastroesophageal reflux disease? General Surgery News (submitted in May 2009). |
||
PEER-REVIEWED ARTICLES |
||
Cadière GB, Rajan A, Dapri G, Rqibate M, Germay O, Himpens J. Nouvelle technique du traitement par voie endoscopique du reflux gastro-oesphagien: la fundoplicature endoluminale. European Journal of Coelio-surgery 2006; 57:14-19. |
||
Cadière GB, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surgical Endoscopy 2007 Dec 11 [on line first DOI 10.1007/s00464-007-9618-9]. |
||
PUBLISHED ABSTRACTS |
||
Arezzo A. Endoluminal fundoplication for GERD past, present and future. Surgical Endoscopy 2007; 21:S76. Bouvy N, Witteman B, van Dam R, Hameeteman W, Koek G. EsophyX™ endoluminal fundoplication (ELF) for the treatment of GERD. Surgical Endoscopy 2007; 21:S315. Conigliaro R, Manta R, Fasone MA, Manno M, Soliman A, Frazzoni M, Melotti G. A novel endoluminal fundoplication technique: EsophyX procedure. Digestive and Liver Disease 2008: 40S:S172. Dapri G, Rajan A, Himpens J, Cadière GB. Transoral incisionless fundoplication: results at two years. Gastrointestinal Endoscopy 2008; 67:AB138. Gawlicka AK, Muls V. EsophyX™ transoral incisionless fundoplication for management of GERD: increase in dietary choices, physical activity and sleep quality at six months. Journal of Clinical Gastroenterology 2008; 42:S18-S19. Jobe BA, Koek GH, Kraemer SJ, McMahon BP, Witteman B, Gravesen FH, Lorenzo CS, O’Rourke RW, Shumaker DA, Owens MM, Hunter JG, Bouvy N. Tailored transoral incisionless fundoplication (TIF) in the treatment of GERD: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel approach. Gastrointestinal Endoscopy 2008. Kraemer SJ, Kozarek RA, Carter BJ, Low DE. EsophyX™ endoluminal fundoplication for the treatment of severe chronic GERD: novel approach for valvuloplasty demonstrated in an animal model. Gastrointestinal Endoscopy 2006; 63(5):AB242. Kraemer SJ, Kozarek RA, Carter BJ, Low DE. EsophyX™ endoluminal fundoplication for the treatment of severe chronic GERD: multiple tissue fasteners secure valvuloplasty as demonstrated in an animal model. Gastrointestinal Endoscopy 2006; 63(5):AB235. McMahon B, Kraemer S, Obermeyer K, Gravesen F, Jobe B. Measuring geometric changes in the esophageal junction as a result of endoluminal treatment of gastro-esophageal reflux disease. Journal of Clinical Gastroenterology 2008; 42:S18. Rajan A, Van Sante N, Gawlicka AK, Cadière GB. Transoral incisionless fundoplication using EsophyX™ for the treatment of GERD: two-year results of a feasibility study. Journal of Clinical Gastroenterology 2008; 42:S19. Repici A, Barbera R, Fumagalli U, Gambaro C, Pagano N, De Caro G, Romeo F, Omodei P, Malesci A, Rosati R. Endoluminal fundoplication with EsophyX device in the treatment of reflux disease. Digestive and Liver Disease 2008; 40S:S18. Repici A, Barbera R, Gambaro C, Fumagalli U, Malesci A, Rosati R. Endoluminal fundoplication with the EsophyX device for the treatment of GERD. A prospective study with 6-month follow up. Gastrointestinal Endoscopy 2008; 67(5):AB139. Youd PL, Emmanuel AV, Gould S, Arebi N, Gurmany S, Fraser CH. The EsophyX endoluminal fundoplication device for GORD: the first patients from the United Kingdom. Gastrointestinal Endoscopy 2007; 65(5):AB284. Youd P, Emmanuel AV, Tripoli E, Roy AJ, Konieczko K, Harris J, Fraser CH. Endogastric anti-reflux therapy using the EsophyX endoluminal fundoplication device: results of the first U.K. study. Gastrointestinal Endoscopy 2008; 67(5):AB144. |
||
PRESENTATIONS |
||
Cadière GB, Rajan A, Dapri A. Feasibility study of endoluminal fundoplication (ELF) device (EsophyX) in patients referred for Nissen fundoplication surgery. SAGES 2006, Dallas, TX, USA, Apr 25-29, 2006; Abstract ETP002. Poster. 2. Corsetti M, Passeretti SM, Di Pietro S, Strini G, Castellaneta AG, Masci E, Mangiavillano B, Testoni PA. Effect of the EsophyX device for endoluminal fundoplication on symptoms, esophageal manometry and pH-impedence of patients with gastro-esophageal reflux. DDW2008, San Diego, CA, USA, May 17-22. Oral presentation. Dapri G, Rajan A, Himpens J, Cadière GB. Transoral incisionless fundoplication: results at two years. DDW2008, San Diego, CA, USA, May 17-22. Poster. de Vries EE, Witteman BPL, van Dam RM, Hameeteman W, Koek G, Bouvy ND. Endoluminal fundoplication for the treatment of gastroesophageal reflux disease. The 42nd Congress of the European Society for Surgical Research (ESSR), Rotterdam, The Netherlands, May 23-26, 2007; Abstract O057. Poster. Gawlicka AK, Muls V. EsophyX™ transoral incisionless fundoplication for management of GERD: increase in dietary choices, physical activity and sleep quality at six months. 9th OESO Congress on GERD, Monte Carlo, Monaco, Apr 6-9, 2008; Abstract 98. Poster. Kraemer S. What are the current indications for endo-luminal gastroplication? The 9th OESO Congress on GERD, Monte Carlo, Monaco, Apr 6-9, 2008; Invited speaker. Kraemer SJ, Carter BJ, Adams JM. EsophyX™ endoluminal fundoplication (ELF) for the treatment of severe chronic GERD: valvuloplasty with novel tissue fasteners; “dosage” in an animal model. SAGES 2006, Dallas, TX, USA, Apr 25-29, 2006; Abstract ETP012. Poster. Kraemer SJ, Carter BJ, Adams JM. EsophyX™ endoluminal fundoplication (ELF) for the treatment of severe chronic GERD: a novel approach for valvuloplasty demonstrated in an animal model. SAGES 2006, Dallas, TX, USA, Apr 25-29, 2006; Abstract ETP013. Poster. Kraemer SJ, Kozarek RA, Carter BJ, Low DE. EsophyX™ Endoluminal Fundoplication (ELF) for the treatment of severe chronic GERD: valvuloplasty with novel tissue fasteners; “dosage” in an animal model. DDW 2006, Los Angeles, CA, USA, May 20-25, 2006; Abstract T1500. Poster. Lorenzo C, Jobe BA, Koek GH, Kraemer SJ, McMahon BP, Witteman B, Gravesen FH, Lorenzo CS, O’Rourke RW, Shumaker DA, Owens MM, Hunter JG, Bouvy N. Transoral incisionless fundoplication: results at two years. DDW2008, San Diego, CA, USA, May 17-22. Oral presentation. McMahon B, Kraemer S, Obermeyer K, Gravesen F, Jobe B. Measuring geometric changes in the esophageal junction as a result of endoluminal treatment of gastro-esophageal reflux disease. The 9th OESO Congress on GERD, Monte Carlo, Monaco, Apr 6-9, 2008; Abstract 97. Poster. Perretta S, Dallemagne B, Marescaux J. Manometric profile after laparoscopic Nissen fundoplication and endoluminal fundoplication: a comparative study in animals. DW2008, San Diego, CA, USA, May 17-22. Oral presentation. Rajan A, Cadière GB. Endoluminal fundoplication (ELF) for the treatment of GERD: an initial feasibility study. The 14th United European Gastroenterology Week (UEGW) 2006, Berlin, Germany, October 21-25, 2006. Poster. Rajan A, Van Sante N, Gawlicka AK, Cadière GB. Transoral incisionless fundoplication using EsophyX™ for the treatment of GERD: two-year results of a feasibility study. The 9th OESO Congress on GERD, Monte Carlo, Monaco, Apr 6-9, 2008; Abstract 99. Poster. |
||
CITATIONS |
||
Marchese M, Spada C, Costamagna G. Endoluminal fundoplication. Minimally Invasive Therapy 2006; 15:356-365. |
||
Reavis KM, Melvin WS. Advanced endoscopic technologies. Surgical Endoscopy 2008; 22: 1533-1546. |
||
Testoni PA, Castellaneta GL, Masci E. Endoluminal fundoplication for the treatment of gastro-oesophageal reflux disease. European Gastroenterology Review 2007; December:48-50. |
||
|
||
*References available upon request*
NP01926-01A



